Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Price:
999 999.9999 JPY
Market Closed
Updated:
Apr 29, 2024
Taisho Pharmaceutical Holdings Co Ltd
Operating Income
|
Taisho Pharmaceutical Holdings Co Ltd
Operating Income Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
Operating Income
¥18.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Income
¥464.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Income
¥188B
|
CAGR 3-Years
37%
|
CAGR 5-Years
19%
|
CAGR 10-Years
5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Income
¥294.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
32%
|
CAGR 10-Years
3%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Income
¥444.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Income
¥142B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
3%
|
See Also
What is Taisho Pharmaceutical Holdings Co Ltd's Operating Income?
Operating Income
18.9B
JPY
18.9B
JPY
Based on the financial report for Dec 31, 2023, Taisho Pharmaceutical Holdings Co Ltd's Operating Income amounts to 18.9B JPY.
What is Taisho Pharmaceutical Holdings Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-7%
-7%
Over the last year, the Operating Income growth was -29%. The average annual Operating Income growth rates for Taisho Pharmaceutical Holdings Co Ltd have been -9% over the past three years , -12% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
